5 AstraZeneca雇员因数据违规和未经批准进口毒品而被拘留在中国。 5 AstraZeneca employees detained in China over data irregularities & unapproved drug import.

中国当局在调查潜在数据违规和进口未经批准的肝癌药物时拘留了AstraZeneca的五名雇员。 Chinese authorities have detained five employees of AstraZeneca amid investigations into potential data irregularities and the import of an unapproved liver cancer drug. 由深圳警方牵头的调查针对的是据称与病人数据收集有关的非法活动。 The inquiry, led by Shenzhen police, targets alleged illegal activities related to patient data collection. 这种情况对AstraZeneca在中国的业务造成风险,而该公司的收入占其收入的12%。 This situation poses risks to AstraZeneca's operations in China, which contribute 12% to its revenues. 该公司尚未就拘留发表声明。 The company has not yet issued a statement regarding the detentions.